These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20210988)

  • 41. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
    Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
    AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.
    Peters PJ; Sullivan WM; Duenas-Decamp MJ; Bhattacharya J; Ankghuambom C; Brown R; Luzuriaga K; Bell J; Simmonds P; Ball J; Clapham PR
    J Virol; 2006 Jul; 80(13):6324-32. PubMed ID: 16775320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
    Huang W; Eshleman SH; Toma J; Fransen S; Stawiski E; Paxinos EE; Whitcomb JM; Young AM; Donnell D; Mmiro F; Musoke P; Guay LA; Jackson JB; Parkin NT; Petropoulos CJ
    J Virol; 2007 Aug; 81(15):7885-93. PubMed ID: 17507467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy.
    Bon I; Turriziani O; Musumeci G; Clò A; Montagna C; Morini S; Calza L; Gibellini D; Antonelli G; Re MC
    J Med Virol; 2015 Feb; 87(2):315-22. PubMed ID: 25138591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption.
    Silva WP; Santos DE; Leal E; Brunstein A; Sucupira MC; Sabino EC; Diaz RS
    Virology; 2006 Oct; 354(1):35-47. PubMed ID: 16872654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.
    van Rij RP; Blaak H; Visser JA; Brouwer M; Rientsma R; Broersen S; de Roda Husman AM; Schuitemaker H
    J Clin Invest; 2000 Oct; 106(8):1039-52. PubMed ID: 11032864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal ultradeep characterization of HIV type 1 R5 and X4 subpopulations in patients followed from primary infection to coreceptor switch.
    Hedskog C; Brodin J; Heddini A; Bratt G; Albert J; Mild M
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1237-44. PubMed ID: 23745959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
    Chaix ML; Seng R; Frange P; Tran L; Avettand-Fenoël V; Ghosn J; Reynes J; Yazdanpanah Y; Raffi F; Goujard C; Rouzioux C; Meyer L;
    Clin Infect Dis; 2013 Mar; 56(6):880-7. PubMed ID: 23223603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maraviroc (Celsentri) for multidrug-resistant human immunodeficiency virus (HIV)-1.
    Ndegwa S
    Issues Emerg Health Technol; 2007 Dec; (110):1-8. PubMed ID: 18080399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation.
    Henrich TJ; Hu Z; Li JZ; Sciaranghella G; Busch MP; Keating SM; Gallien S; Lin NH; Giguel FF; Lavoie L; Ho VT; Armand P; Soiffer RJ; Sagar M; Lacasce AS; Kuritzkes DR
    J Infect Dis; 2013 Jun; 207(11):1694-702. PubMed ID: 23460751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reconstitution of HIV-1 reservoir following high-dose chemotherapy/autologous stem cell transplantation for lymphoma.
    Delagreverie HM; Gerard L; Chaillon A; Roelens M; Djerroudi L; Salmona M; Larghero J; Galicier L; Simon F; Oksenhendler E; Moins-Teisserenc H; Delaugerre C
    AIDS; 2019 Feb; 33(2):247-257. PubMed ID: 30325771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
    Cummins NW; Rizza S; Litzow MR; Hua S; Lee GQ; Einkauf K; Chun TW; Rhame F; Baker JV; Busch MP; Chomont N; Dean PG; Fromentin R; Haase AT; Hampton D; Keating SM; Lada SM; Lee TH; Natesampillai S; Richman DD; Schacker TW; Wietgrefe S; Yu XG; Yao JD; Zeuli J; Lichterfeld M; Badley AD
    PLoS Med; 2017 Nov; 14(11):e1002461. PubMed ID: 29182633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.
    Dalmau J; Puertas MC; Azuara M; Mariño A; Frahm N; Mothe B; Izquierdo-Useros N; Buzón MJ; Paredes R; Matas L; Allen TM; Brander C; Rodrigo C; Clotet B; Martinez-Picado J
    Clin Infect Dis; 2009 Jan; 48(2):229-38. PubMed ID: 19093810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant.
    Salgado M; Kwon M; Gálvez C; Badiola J; Nijhuis M; Bandera A; Balsalobre P; Miralles P; Buño I; Martinez-Laperche C; Vilaplana C; Jurado M; Clotet B; Wensing A; Martinez-Picado J; Diez-Martin JL;
    Ann Intern Med; 2018 Nov; 169(10):674-683. PubMed ID: 30326031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term control of viral replication in a Group O, human immunodeficiency virus type 1-infected individual.
    Buckheit RW; Sexauer SB; Sedaghat AR; Wilke CO; Laeyendecker O; Basseth CR; Blankson JN
    AIDS Res Hum Retroviruses; 2014 Jun; 30(6):511-3. PubMed ID: 24798496
    [No Abstract]   [Full Text] [Related]  

  • 57. Generation of representative primary virus isolates from blood plasma after isolation of HIV-1 with CD44 MicroBeads.
    Cornelissen M; Heeregrave EJ; Zorgdrager F; Pollakis G; Paxton WA; van der Kuyl AC
    Arch Virol; 2010 Dec; 155(12):2017-22. PubMed ID: 20865288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal HIV-1 gp120-C2V3C3 phylogenetic surveillance and tropism evolution in patients under HAART.
    Moretti FA; Gómez-Carrillo M; Quarleri JF
    Virus Genes; 2013 Jun; 46(3):404-11. PubMed ID: 23463174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.
    Henrich TJ; Hanhauser E; Marty FM; Sirignano MN; Keating S; Lee TH; Robles YP; Davis BT; Li JZ; Heisey A; Hill AL; Busch MP; Armand P; Soiffer RJ; Altfeld M; Kuritzkes DR
    Ann Intern Med; 2014 Sep; 161(5):319-27. PubMed ID: 25047577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between CD4 T cell counts and virus compartmentalization in genital and systemic compartments of HIV-infected females.
    Chaudhary S; Noel RJ; Rodríguez N; Collado S; Munoz J; Kumar A; Yamamura Y
    Virology; 2011 Sep; 417(2):320-6. PubMed ID: 21745672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.